We are thrilled to announce that Aitia will be participating in the CNS Summit 2023 conference. Colin Hill, will be joined by Rudolph Tanzi, Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School, and Ole Isacson, Professor & Chair of Institute of Harvard Medical School to talk about AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease.

Spotlight Session: Can Digital Twins Drive the Discovery and Clinical Development of the Next Generation of AD Drugs?

During the session, the panel will delve into the latest advancements in Alzheimer’s Disease research and participate in discussions about harnessing Digital Twins to propel the discovery and clinical development of the next wave of drugs for Alzheimer’s Disease.

More information on the CNS Summit 2023 conference here.